Literature DB >> 23322550

Comparison of nanotube-protein corona composition in cell culture media.

Jonathan H Shannahan1, Jared M Brown, Ran Chen, Pu Chun Ke, Xianyin Lai, Somenath Mitra, Frank A Witzmann.   

Abstract

In biological environments, nanomaterials associate with proteins forming a protein corona (PC). The PC may alter the nanomaterial's pharmacokinetics and pharmacodynamics, thereby influencing toxicity. Using a label-free mass spectrometry-based proteomics approach, the composition of the PC is examined for a set of nanotubes (NTs) including unmodified and carboxylated single- (SWCNT) and multi-walled carbon nanotubes (MWCNT), polyvinylpyrrolidone (PVP)-coated MWCNT (MWCNT-PVP), and nanoclay. NTs are incubated for 1 h in simulated cell culture conditions, then washed, resuspended in PBS, and assessed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) for their associated PC. To determine those attributes that influence PC formation, the NTs are extensively characterized. NTs had negative zeta potentials in water (SWCNT-COOH < MWCNT-COOH < unmodified NTs) while carboxylation increases their hydrodynamic sizes. All NTs are also found to associate a common subset of proteins including albumin, titin, and apolipoproteins. SWCNT-COOH and MWCNT-COOH are found to bind the greatest number of proteins (181 and 133 respectively) compared to unmodified NTs (<100), suggesting covalent binding to protein amines. Modified NTs bind a number of unique proteins compared to unmodified NTs, implying hydrogen bonding and electrostatic interactions are involved in PC formation. PVP-coating of MWCNT did not influence PC composition, further reinforcing the possibility of hydrogen bonding and electrostatic interactions. No relationships are found between PC composition and corresponding isoelectric point, hydropathy, or aliphatic index, implying minimal roles of hydrophobic interaction and pi-stacking.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23322550      PMCID: PMC3725593          DOI: 10.1002/smll.201202243

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  48 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake.

Authors:  Lénaic Lartigue; Claire Wilhelm; Jacques Servais; Cécile Factor; Anne Dencausse; Jean-Claude Bacri; Nathalie Luciani; Florence Gazeau
Journal:  ACS Nano       Date:  2012-02-16       Impact factor: 15.881

Review 3.  Molecular interaction of proteins and peptides with nanoparticles.

Authors:  Anton A Shemetov; Igor Nabiev; Alyona Sukhanova
Journal:  ACS Nano       Date:  2012-05-31       Impact factor: 15.881

4.  A novel alignment method and multiple filters for exclusion of unqualified peptides to enhance label-free quantification using peptide intensity in LC-MS/MS.

Authors:  Xianyin Lai; Lianshui Wang; Haixu Tang; Frank A Witzmann
Journal:  J Proteome Res       Date:  2011-09-21       Impact factor: 4.466

5.  Investigation of an albumin-enriched fraction of human serum and its albuminome.

Authors:  Rebekah L Gundry; Qin Fu; Christine A Jelinek; Jennifer E Van Eyk; Robert J Cotter
Journal:  Proteomics Clin Appl       Date:  2007-01-01       Impact factor: 3.494

6.  Assessment of an ad hoc procedure for isolation and characterization of human albuminome.

Authors:  Domenica Scumaci; Marco Gaspari; Milena Saccomanno; Giuseppe Argirò; Barbara Quaresima; Concetta M Faniello; Pietrantonio Ricci; Francesco Costanzo; Giovanni Cuda
Journal:  Anal Biochem       Date:  2011-06-30       Impact factor: 3.365

7.  The evolution of the protein corona around nanoparticles: a test study.

Authors:  Martin Lundqvist; Johannes Stigler; Tommy Cedervall; Tord Berggård; Michelle B Flanagan; Iseult Lynch; Giuliano Elia; Kenneth Dawson
Journal:  ACS Nano       Date:  2011-08-26       Impact factor: 15.881

8.  Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis.

Authors:  T Blunk; D F Hochstrasser; J C Sanchez; B W Müller; R H Müller
Journal:  Electrophoresis       Date:  1993-12       Impact factor: 3.535

9.  Quantitative mechanics of endothelial phagocytosis of silicon microparticles.

Authors:  Rita E Serda; Jianhua Gu; Jared K Burks; Kim Ferrari; Chiara Ferrari; Mauro Ferrari
Journal:  Cytometry A       Date:  2009-09       Impact factor: 4.355

10.  Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol-DOPE/DNA lipoplexes in serum.

Authors:  Giulio Caracciolo; Luciano Callipo; Sofia Candeloro De Sanctis; Chiara Cavaliere; Daniela Pozzi; Aldo Laganà
Journal:  Biochim Biophys Acta       Date:  2009-11-14
View more
  43 in total

1.  Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states.

Authors:  Sherleen Xue-Fu Adamson; Zhoumeng Lin; Ran Chen; Lisa Kobos; Jonathan Shannahan
Journal:  Toxicol In Vitro       Date:  2018-05-05       Impact factor: 3.500

2.  Charge-transfer interactions induce surface dependent conformational changes in apolipoprotein biocorona.

Authors:  Achyut J Raghavendra; Nasser Alsaleh; Jared M Brown; Ramakrishna Podila
Journal:  Biointerphases       Date:  2017-03-07       Impact factor: 2.456

3.  Aqueous cationic, anionic and non-ionic multi-walled carbon nanotubes, functionalised with minimal framework damage, for biomedical application.

Authors:  Shu Chen; Sheng Hu; Elizabeth F Smith; Pakatip Ruenraroengsak; Andrew J Thorley; Robert Menzel; Angela E Goode; Mary P Ryan; Teresa D Tetley; Alexandra E Porter; Milo S P Shaffer
Journal:  Biomaterials       Date:  2014-03-14       Impact factor: 12.479

Review 4.  Safe clinical use of carbon nanotubes as innovative biomaterials.

Authors:  Naoto Saito; Hisao Haniu; Yuki Usui; Kaoru Aoki; Kazuo Hara; Seiji Takanashi; Masayuki Shimizu; Nobuyo Narita; Masanori Okamoto; Shinsuke Kobayashi; Hiroki Nomura; Hiroyuki Kato; Naoyuki Nishimura; Seiichi Taruta; Morinobu Endo
Journal:  Chem Rev       Date:  2014-04-10       Impact factor: 60.622

5.  Altered formation of the iron oxide nanoparticle-biocorona due to individual variability and exercise.

Authors:  Lisa M Kobos; Sherleen Xue-Fu Adamson; Sheelagh Evans; Timothy P Gavin; Jonathan H Shannahan
Journal:  Environ Toxicol Pharmacol       Date:  2018-07-29       Impact factor: 4.860

Review 6.  Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Authors:  Eileen D Kuempel; Marie-Claude Jaurand; Peter Møller; Yasuo Morimoto; Norihiro Kobayashi; Kent E Pinkerton; Linda M Sargent; Roel C H Vermeulen; Bice Fubini; Agnes B Kane
Journal:  Crit Rev Toxicol       Date:  2016-08-18       Impact factor: 5.635

7.  Impacts of Organomodified Nanoclays and Their Incinerated Byproducts on Bronchial Cell Monolayer Integrity.

Authors:  Todd A Stueckle; Andrew White; Alixandra Wagner; Rakesh K Gupta; Yon Rojanasakul; Cerasela Z Dinu
Journal:  Chem Res Toxicol       Date:  2019-11-19       Impact factor: 3.739

8.  NanoEHS beyond Toxicity - Focusing on Biocorona.

Authors:  Sijie Lin; Monika Mortimer; Ran Chen; Aleksandr Kakinen; Jim E Riviere; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Environ Sci Nano       Date:  2017-06-01

Review 9.  Vascular distribution of nanomaterials.

Authors:  Phoebe A Stapleton; Timothy R Nurkiewicz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-04-28

Review 10.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

Authors:  Claudia Corbo; Roberto Molinaro; Alessandro Parodi; Naama E Toledano Furman; Francesco Salvatore; Ennio Tasciotti
Journal:  Nanomedicine (Lond)       Date:  2015-12-11       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.